FDA Drug Recalls

Recalls / Class II

Class IID-0324-2025

Product

Nitroglycerin Sublingual Tablets 0.4MG 100-count carton, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-639-45.

Brand name
Nitroglycerin
Generic name
Nitroglycerin
Active ingredient
Nitroglycerin
Route
Sublingual
NDCs
68462-638, 68462-639, 68462-640
FDA application
ANDA206391
Affected lot / code info
Lot # 17232024, exp. date Aug-25 17232071, exp. date Sep-25 17232072, exp. date Sep-25

Why it was recalled

CGMP Deviations

Recalling firm

Firm
Glenmark Pharmaceuticals Inc., USA
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
750 Corporate Dr, N/A, Mahwah, New Jersey 07430-2009

Distribution

Quantity
N/A
Distribution pattern
U.S. Nationwide

Timeline

Recall initiated
2025-03-13
FDA classified
2025-04-08
Posted by FDA
2025-04-16
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0324-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.